ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Chronic Obstructive Pulmonary Disease in Patients Undergoing Transcatheter Aortic Valve Implantation:

Wednesday, October 23, 2013

Submitted by

Source

Source Name: JACC Cardiovascular Interventions

Source URL: http://interventions.onlinejacc.org/article.aspx?articleid=1758480

Author(s)

Michael Mok; Luis Nombela-Franco; Eric Dumont; Marina Urena; Robert DeLarochellière; Daniel Doyle; Jacques Villeneuve; Mélanie Côté; Henrique B. Ribeiro; Ricardo Allende; Jerôme Laflamme; Hugo DeLarochellière; Louis Laflamme; Ignacio Amat-Santos; Philippe Pibarot; François Maltais; Josep Rodés-Cabau

This study evaluated the effects of COPD on outcomes after TAVI in 319 pts, 30% of whom had COPD. COPD pts had a lower survival rate at 1 yr (71% vs 85%) and experienced less improvement in functional status. Cumulative mortality was predicted by the 6 min walk test, and periprocedural pulmonary complications were predicted by FEV1. TAVI was deemed futile in 40% of COPD pts.